Dr. Klaus Pors

Klaus Pors graduated with a BEng in chemical engineering from the University of Southern Denmark (Odense, Denmark) in 1998 and completed his studies in medicinal chemistry at the UCL School of Pharmacy in 2002. Both his PhD and Postdoc (UCL School of Pharmacy, 2002–2005) were focused on the discovery of anticancer agents and hypoxia-activated prodrugs to treat solid tumours. In 2005, he relocated to Bradford to take up a Yorkshire Cancer Research-funded lectureship and a team leader position at the Institute of Cancer Therapeutics with a focus on the discovery of tumour-selective therapies. He was promoted to senior lecturer in 2013 and professor of chemical biology in 2021. His current research interests include the discovery of chemical and biological tools for biomedical research and the translation of this research for therapeutic intervention in oncology.